Targeted Oncology presents Expert Perspective Virtual Tumor Board, a video editorial series featuring multi-disciplinary collaboration between professionals reviewing patient cases and discussing diagnoses, biomarker testing, and treatment strategies.
Expert Perspectives on the Treatment of Advanced Clear Cell Renal Cell Carcinoma
March 29th 2023A panel of expert genitourinary oncologists present the case of a patient with advanced clear cell renal cell carcinoma and have a comprehensive discussion on clinical trial data and treatment decisions.
Read More
Biomarker Testing in Non-Small Cell Lung Cancer
February 21st 2023Jason Porter, MD, Eric Vail, MD, and Ana Velázquez Mañana, MD, MSc, present two clinical cases of non-small cell lung cancer (NSCLC), discuss targetable genomic alterations and their approaches to biomarker testing for these patients, and touch on how socioeconomic and racial disparities may effect use of testing.
Read More
The Role of BCMA-Directed Therapy in Relapsed Refractory Multiple Myeloma (R/R MM)
February 9th 2023A panel of experts in multiple myeloma reviews key clinical trial data on the treatment of relapsed/refractory multiple myeloma (R/R MM) and discusses the best treatment approaches in the context of recent treatment approvals.
Read More
Advances in Targeted Therapies for Non-Small Cell Lung Cancer
November 10th 2022In this panel discussion, experts review clinical cases of metastatic non-small cell lung cancer (mNSCLC), discuss commonly observed targetable genomic alterations, and share their perspectives on key clinical trial data that could impact treatment decision-making.
Read More
Advances in the Diagnosis and Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
September 30th 2022An expert panel including two hematologist-oncologists and a pathologist center discussion on patient cases to review the optimal identification and management of blastic plasmacytoid dendritic cell neoplasm.
Read More